Share Price and Basic Stock Data
Last Updated: November 22, 2025, 8:08 am
| PEG Ratio | 0.15 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bombay Burmah Trading Corporation Ltd operates primarily in the plantations sector, focusing on tea and coffee production. The company reported a market capitalization of ₹13,772 Cr and a current share price of ₹1,974. Revenue from operations for the fiscal year ending March 2025 stood at ₹18,298 Cr, reflecting a notable increase from ₹16,623 Cr in March 2023. Quarterly sales data indicate a consistent upward trajectory, with sales reaching ₹4,761 Cr in September 2024, up from ₹4,524 Cr in September 2023. This growth trend highlights the company’s ability to expand its market presence and effectively manage its production capabilities amidst competitive pressures. The operating profit margin (OPM) for FY 2025 is reported at 17%, which is indicative of efficient cost management compared to the sector average. Overall, the revenue growth trajectory underscores the company’s robust operational framework and strategic positioning within the industry.
Profitability and Efficiency Metrics
Bombay Burmah Trading Corporation Ltd demonstrated a commendable net profit of ₹2,199 Cr for the fiscal year ending March 2025, a significant recovery from a net loss of ₹534 Cr in March 2023. The company’s return on equity (ROE) stood at 21.9%, while return on capital employed (ROCE) was reported at 35.5%, illustrating strong profitability relative to equity and capital employed. The interest coverage ratio (ICR) was robust at 21.50x, indicating that the company comfortably meets its interest obligations. Additionally, the cash conversion cycle (CCC) was recorded at -6 days, showcasing exceptional efficiency in cash flow management. This negative CCC indicates that the company collects cash from its customers before it needs to pay its suppliers, thus enhancing liquidity. The operating profit consistently exceeded ₹3,000 Cr in recent years, underscoring the company’s ability to maintain profitability even in challenging market conditions.
Balance Sheet Strength and Financial Ratios
The balance sheet of Bombay Burmah Trading Corporation Ltd reflects a strong financial position, with total assets reported at ₹12,721 Cr as of March 2025. The company maintained reserves of ₹5,618 Cr, a significant increase from ₹4,018 Cr in March 2023, indicating sound financial health and retained earnings. The total borrowings stood at ₹1,574 Cr, providing a debt-to-equity ratio of 0.27, which is low and suggests prudent financial leverage. The price-to-book value (P/BV) ratio was reported at 2.19x, which is relatively high compared to typical sector ranges, indicating that the market values the company’s equity at a premium. Furthermore, the current ratio of 1.07 and a quick ratio of 0.75 suggest that the company is in a position to meet its short-term obligations, although the quick ratio indicates a potential liquidity risk. Overall, the balance sheet exhibits strength, with manageable debt levels and significant equity backing.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Bombay Burmah Trading Corporation Ltd reveals strong promoter confidence, with promoters holding 74.05% of the equity as of March 2025. This substantial ownership reflects a commitment to the company’s long-term vision and strategy. Foreign institutional investors (FIIs) accounted for 9.30% of the shareholding, showing a stable interest from international investors. Domestic institutional investors (DIIs) comprised 1.43%, while the public held 15.22%. Notably, the number of shareholders increased to 44,643, indicating growing interest and confidence among retail investors. However, the gradual decline in public shareholding from 16.95% in December 2022 to 15.22% in March 2025 may raise concerns about the dilution of retail participation. Overall, the shareholding structure reflects solid backing from promoters and institutional investors, contributing to market confidence.
Outlook, Risks, and Final Insight
Looking ahead, Bombay Burmah Trading Corporation Ltd is poised for continued growth, driven by its strong operational metrics and recovery in profitability. However, risks such as fluctuations in commodity prices, particularly tea and coffee, and potential regulatory changes in the agricultural sector may impact financial performance. Additionally, the company’s high dependence on a limited number of product lines could pose risks if market preferences shift. On the upside, further expansion in both domestic and international markets could provide new revenue streams. The company’s robust financial metrics and supportive shareholder structure position it well for future challenges. Ultimately, maintaining operational efficiency and adapting to market dynamics will be crucial for sustaining growth and profitability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Bombay Burmah Trading Corporation Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 399 Cr. | 185 | 309/162 | 149 | 0.00 % | 3.22 % | 2.86 % | 10.0 | |
| Diana Tea Company Ltd | 43.9 Cr. | 29.3 | 43.8/26.0 | 47.3 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
| Bengal Tea & Fabrics Ltd | 123 Cr. | 137 | 189/126 | 24.0 | 223 | 1.10 % | 5.22 % | 55.3 % | 10.0 |
| Bansisons Tea Industries Ltd | 6.96 Cr. | 11.0 | 11.0/5.60 | 9.42 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
| B&A Ltd | 127 Cr. | 410 | 689/392 | 13.6 | 528 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
| Industry Average | 9,051.82 Cr | 410.42 | 73.82 | 265.00 | 0.41% | 7.88% | 16.74% | 7.00 |
All Competitor Stocks of Bombay Burmah Trading Corporation Ltd
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,776 | 4,459 | 4,280 | 4,108 | 4,087 | 4,524 | 4,337 | 4,162 | 4,333 | 4,761 | 4,685 | 4,519 | 4,712 |
| Expenses | 3,654 | 4,056 | 3,756 | 3,431 | 3,748 | 3,737 | 3,538 | 3,399 | 3,598 | 4,037 | 3,811 | 3,717 | 3,988 |
| Operating Profit | 121 | 403 | 524 | 678 | 339 | 787 | 799 | 763 | 736 | 724 | 873 | 802 | 724 |
| OPM % | 3% | 9% | 12% | 16% | 8% | 17% | 18% | 18% | 17% | 15% | 19% | 18% | 15% |
| Other Income | 150 | 118 | 483 | -1,532 | 97 | 66 | 269 | 105 | 29 | 187 | 81 | 109 | 74 |
| Interest | 89 | 112 | 110 | 113 | 127 | 155 | 53 | 29 | 31 | 37 | 51 | 39 | 34 |
| Depreciation | 55 | 55 | 61 | 69 | 74 | 75 | 81 | 84 | 77 | 80 | 86 | 84 | 86 |
| Profit before tax | 128 | 353 | 836 | -1,037 | 235 | 624 | 934 | 756 | 656 | 794 | 818 | 788 | 678 |
| Tax % | 100% | 49% | 26% | 29% | 71% | 34% | 22% | 27% | 28% | 35% | 23% | 26% | 27% |
| Net Profit | 0 | 181 | 618 | -1,334 | 68 | 412 | 731 | 549 | 472 | 516 | 627 | 585 | 498 |
| EPS in Rs | -23.62 | -8.63 | 22.60 | -230.58 | -22.38 | 17.49 | 65.46 | 40.73 | 31.86 | 36.22 | 48.58 | 44.24 | 34.50 |
Last Updated: August 20, 2025, 12:40 pm
Below is a detailed analysis of the quarterly data for Bombay Burmah Trading Corporation Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 4,712.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,519.00 Cr. (Mar 2025) to 4,712.00 Cr., marking an increase of 193.00 Cr..
- For Expenses, as of Jun 2025, the value is 3,988.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,717.00 Cr. (Mar 2025) to 3,988.00 Cr., marking an increase of 271.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 724.00 Cr.. The value appears to be declining and may need further review. It has decreased from 802.00 Cr. (Mar 2025) to 724.00 Cr., marking a decrease of 78.00 Cr..
- For OPM %, as of Jun 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Mar 2025) to 15.00%, marking a decrease of 3.00%.
- For Other Income, as of Jun 2025, the value is 74.00 Cr.. The value appears to be declining and may need further review. It has decreased from 109.00 Cr. (Mar 2025) to 74.00 Cr., marking a decrease of 35.00 Cr..
- For Interest, as of Jun 2025, the value is 34.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 39.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 5.00 Cr..
- For Depreciation, as of Jun 2025, the value is 86.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 84.00 Cr. (Mar 2025) to 86.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 678.00 Cr.. The value appears to be declining and may need further review. It has decreased from 788.00 Cr. (Mar 2025) to 678.00 Cr., marking a decrease of 110.00 Cr..
- For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Mar 2025) to 27.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 498.00 Cr.. The value appears to be declining and may need further review. It has decreased from 585.00 Cr. (Mar 2025) to 498.00 Cr., marking a decrease of 87.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 34.50. The value appears to be declining and may need further review. It has decreased from 44.24 (Mar 2025) to 34.50, marking a decrease of 9.74.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:37 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7,271 | 8,197 | 8,762 | 9,434 | 10,238 | 11,423 | 11,889 | 13,396 | 14,507 | 16,623 | 17,109 | 18,298 | 18,858 |
| Expenses | 6,642 | 7,335 | 7,558 | 8,164 | 8,919 | 9,741 | 10,138 | 11,247 | 12,912 | 14,897 | 14,242 | 15,162 | 15,522 |
| Operating Profit | 629 | 861 | 1,204 | 1,270 | 1,319 | 1,683 | 1,751 | 2,150 | 1,595 | 1,726 | 2,867 | 3,136 | 3,336 |
| OPM % | 9% | 11% | 14% | 13% | 13% | 15% | 15% | 16% | 11% | 10% | 17% | 17% | 18% |
| Other Income | 88 | 295 | 161 | 186 | 201 | 391 | 440 | 338 | 384 | -781 | 290 | 406 | 348 |
| Interest | 43 | 41 | 44 | 43 | 55 | 60 | 124 | 151 | 252 | 425 | 364 | 159 | 165 |
| Depreciation | 94 | 155 | 126 | 131 | 153 | 172 | 200 | 213 | 213 | 239 | 313 | 326 | 344 |
| Profit before tax | 579 | 961 | 1,195 | 1,282 | 1,312 | 1,841 | 1,868 | 2,124 | 1,514 | 281 | 2,479 | 3,057 | 3,175 |
| Tax % | 31% | 28% | 34% | 33% | 41% | 35% | 31% | 40% | 47% | 290% | 32% | 28% | |
| Net Profit | 402 | 696 | 792 | 858 | 773 | 1,189 | 1,280 | 1,278 | 809 | -534 | 1,689 | 2,199 | 2,276 |
| EPS in Rs | 29.68 | 51.15 | 55.36 | 60.45 | 39.76 | 89.00 | 85.75 | 52.96 | 9.09 | -240.22 | 91.24 | 160.90 | 161.96 |
| Dividend Payout % | 3% | 2% | 2% | 2% | 3% | 1% | 1% | 2% | 13% | -0% | 1% | 11% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 73.13% | 13.79% | 8.33% | -9.91% | 53.82% | 7.65% | -0.16% | -36.70% | -166.01% | 416.29% | 30.20% |
| Change in YoY Net Profit Growth (%) | 0.00% | -59.34% | -5.46% | -18.24% | 63.72% | -46.16% | -7.81% | -36.54% | -129.31% | 582.30% | -386.10% |
Bombay Burmah Trading Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 9% |
| 3 Years: | 8% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 14% |
| 3 Years: | 161% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 7% |
| 3 Years: | 27% |
| 1 Year: | -32% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -9% |
| 3 Years: | -19% |
| Last Year: | 22% |
Last Updated: September 5, 2025, 1:15 am
Balance Sheet
Last Updated: July 25, 2025, 3:28 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 1,280 | 1,552 | 1,899 | 3,664 | 3,950 | 4,403 | 5,080 | 5,462 | 5,483 | 4,018 | 4,614 | 5,618 |
| Borrowings | 787 | 883 | 793 | 1,014 | 1,024 | 956 | 2,045 | 2,670 | 5,880 | 6,542 | 2,161 | 1,574 |
| Other Liabilities | 1,601 | 2,043 | 2,442 | 2,699 | 3,344 | 4,054 | 4,190 | 4,271 | 3,874 | 5,103 | 5,121 | 5,515 |
| Total Liabilities | 3,682 | 4,493 | 5,148 | 7,391 | 8,332 | 9,427 | 11,329 | 12,418 | 15,251 | 15,677 | 11,911 | 12,721 |
| Fixed Assets | 1,875 | 1,878 | 1,989 | 2,217 | 2,373 | 2,717 | 2,889 | 2,802 | 2,763 | 3,638 | 3,751 | 3,880 |
| CWIP | 114 | 49 | 91 | 33 | 207 | 108 | 51 | 131 | 561 | 108 | 189 | 90 |
| Investments | 430 | 779 | 1,071 | 2,365 | 2,832 | 3,221 | 4,998 | 4,638 | 3,818 | 4,795 | 4,281 | 5,332 |
| Other Assets | 1,263 | 1,786 | 1,997 | 2,776 | 2,920 | 3,381 | 3,391 | 4,847 | 8,109 | 7,136 | 3,690 | 3,419 |
| Total Assets | 3,682 | 4,493 | 5,148 | 7,391 | 8,332 | 9,427 | 11,329 | 12,418 | 15,251 | 15,677 | 11,911 | 12,721 |
Below is a detailed analysis of the balance sheet data for Bombay Burmah Trading Corporation Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
- For Reserves, as of Mar 2025, the value is 5,618.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,614.00 Cr. (Mar 2024) to 5,618.00 Cr., marking an increase of 1,004.00 Cr..
- For Borrowings, as of Mar 2025, the value is 1,574.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,161.00 Cr. (Mar 2024) to 1,574.00 Cr., marking a decrease of 587.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 5,515.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,121.00 Cr. (Mar 2024) to 5,515.00 Cr., marking an increase of 394.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 12,721.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11,911.00 Cr. (Mar 2024) to 12,721.00 Cr., marking an increase of 810.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 3,880.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,751.00 Cr. (Mar 2024) to 3,880.00 Cr., marking an increase of 129.00 Cr..
- For CWIP, as of Mar 2025, the value is 90.00 Cr.. The value appears to be declining and may need further review. It has decreased from 189.00 Cr. (Mar 2024) to 90.00 Cr., marking a decrease of 99.00 Cr..
- For Investments, as of Mar 2025, the value is 5,332.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,281.00 Cr. (Mar 2024) to 5,332.00 Cr., marking an increase of 1,051.00 Cr..
- For Other Assets, as of Mar 2025, the value is 3,419.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,690.00 Cr. (Mar 2024) to 3,419.00 Cr., marking a decrease of 271.00 Cr..
- For Total Assets, as of Mar 2025, the value is 12,721.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,911.00 Cr. (Mar 2024) to 12,721.00 Cr., marking an increase of 810.00 Cr..
Notably, the Reserves (5,618.00 Cr.) exceed the Borrowings (1,574.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -158.00 | -22.00 | -792.00 | 0.00 | 0.00 | -955.00 | -1.00 | 0.00 | -4.00 | -5.00 | 0.00 | 2.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 9 | 9 | 10 | 9 | 13 | 15 | 11 | 9 | 10 | 9 | 10 | 10 |
| Inventory Days | 44 | 39 | 39 | 47 | 43 | 48 | 43 | 56 | 59 | 47 | 47 | 44 |
| Days Payable | 50 | 56 | 58 | 50 | 60 | 64 | 56 | 64 | 54 | 55 | 63 | 61 |
| Cash Conversion Cycle | 2 | -8 | -9 | 5 | -4 | -1 | -1 | 1 | 14 | 1 | -6 | -6 |
| Working Capital Days | -20 | -19 | -13 | 21 | 14 | 21 | -11 | -24 | -39 | -56 | -35 | -27 |
| ROCE % | 24% | 28% | 36% | 27% | 21% | 27% | 24% | 24% | 15% | 16% | 28% | 36% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Nifty Smallcap 250 Index Fund | 9,967 | 0.18 | 1.26 | 9,967 | 2025-04-22 17:25:39 | 0% |
| Motilal Oswal Nifty Smallcap 250 Index Fund | 6,265 | 0.18 | 0.79 | 6,265 | 2025-04-22 17:25:39 | 0% |
| SBI Nifty Smallcap 250 Index Fund | 4,552 | 0.18 | 0.57 | 4,552 | 2025-04-22 17:25:39 | 0% |
| ICICI Prudential Nifty Smallcap 250 Index Fund | 2,470 | 0.18 | 0.31 | 2,470 | 2025-04-22 17:25:39 | 0% |
| HDFC NIFTY Smallcap 250 ETF | 1,128 | 0.18 | 0.14 | 1,128 | 2025-04-22 17:25:39 | 0% |
| HDFC Nifty Smallcap 250 Index Fund | 874 | 0.18 | 0.11 | 874 | 2025-04-22 17:25:39 | 0% |
| Motilal Oswal Nifty 500 Index Fund | 701 | 0.02 | 0.09 | 701 | 2025-04-22 17:25:39 | 0% |
| Edelweiss Nifty Smallcap 250 Index Fund | 194 | 0.18 | 0.02 | 194 | 2025-04-22 17:25:39 | 0% |
| ICICI Prudential S&P BSE 500 ETF | 172 | 0.02 | 0.02 | 172 | 2025-04-22 17:25:39 | 0% |
| HDFC S&P BSE 500 ETF | 9 | 0.02 | 0 | 9 | 2025-04-22 17:25:39 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 160.90 | 98.09 | -240.19 | 9.09 | 52.96 |
| Diluted EPS (Rs.) | 160.90 | 98.09 | -240.19 | 9.09 | 52.96 |
| Cash EPS (Rs.) | 340.69 | 320.35 | 109.37 | 234.88 | 251.42 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 807.16 | 952.73 | 832.81 | 973.01 | 1041.50 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 807.16 | 952.73 | 832.81 | 973.01 | 1041.50 |
| Revenue From Operations / Share (Rs.) | 2622.54 | 2450.67 | 2381.05 | 2083.31 | 1918.85 |
| PBDIT / Share (Rs.) | 487.98 | 501.00 | 464.05 | 370.66 | 394.29 |
| PBIT / Share (Rs.) | 441.18 | 456.12 | 429.77 | 339.89 | 363.82 |
| PBT / Share (Rs.) | 416.77 | 388.89 | 157.63 | 305.17 | 342.21 |
| Net Profit / Share (Rs.) | 293.89 | 275.46 | 75.10 | 204.11 | 220.95 |
| NP After MI And SOA / Share (Rs.) | 160.90 | 98.03 | -240.05 | 9.08 | 52.93 |
| PBDIT Margin (%) | 18.60 | 20.44 | 19.48 | 17.79 | 20.54 |
| PBIT Margin (%) | 16.82 | 18.61 | 18.04 | 16.31 | 18.96 |
| PBT Margin (%) | 15.89 | 15.86 | 6.62 | 14.64 | 17.83 |
| Net Profit Margin (%) | 11.20 | 11.24 | 3.15 | 9.79 | 11.51 |
| NP After MI And SOA Margin (%) | 6.13 | 4.00 | -10.08 | 0.43 | 2.75 |
| Return on Networth / Equity (%) | 19.93 | 14.63 | -41.54 | 1.15 | 6.74 |
| Return on Capital Employeed (%) | 35.48 | 41.37 | 29.15 | 22.59 | 29.71 |
| Return On Assets (%) | 8.82 | 5.72 | -10.64 | 0.41 | 2.97 |
| Long Term Debt / Equity (X) | 0.12 | 0.19 | 1.06 | 0.64 | 0.20 |
| Total Debt / Equity (X) | 0.27 | 0.45 | 1.62 | 1.07 | 0.48 |
| Asset Turnover Ratio (%) | 1.48 | 1.24 | 1.07 | 1.05 | 1.13 |
| Current Ratio (X) | 1.07 | 1.23 | 1.55 | 1.81 | 1.54 |
| Quick Ratio (X) | 0.75 | 0.93 | 1.32 | 1.51 | 1.24 |
| Inventory Turnover Ratio (X) | 14.35 | 6.93 | 6.27 | 5.80 | 6.53 |
| Dividend Payout Ratio (NP) (%) | 11.31 | 1.22 | -0.49 | 0.00 | 2.26 |
| Dividend Payout Ratio (CP) (%) | 8.76 | 0.83 | -0.58 | 0.00 | 1.43 |
| Earning Retention Ratio (%) | 88.69 | 98.78 | 100.49 | 0.00 | 97.74 |
| Cash Earning Retention Ratio (%) | 91.24 | 99.17 | 100.58 | 0.00 | 98.57 |
| Interest Coverage Ratio (X) | 21.50 | 9.61 | 7.63 | 10.28 | 18.32 |
| Interest Coverage Ratio (Post Tax) (X) | 14.02 | 6.58 | 5.15 | 6.63 | 11.27 |
| Enterprise Value (Cr.) | 15508.50 | 14170.57 | 10312.20 | 8595.21 | 10650.14 |
| EV / Net Operating Revenue (X) | 0.84 | 0.82 | 0.62 | 0.59 | 0.79 |
| EV / EBITDA (X) | 4.55 | 4.05 | 3.18 | 3.32 | 3.87 |
| MarketCap / Net Operating Revenue (X) | 0.67 | 0.63 | 0.34 | 0.41 | 0.57 |
| Retention Ratios (%) | 88.68 | 98.77 | 100.49 | 0.00 | 97.73 |
| Price / BV (X) | 2.19 | 2.34 | 1.41 | 1.09 | 1.42 |
| Price / Net Operating Revenue (X) | 0.67 | 0.63 | 0.34 | 0.41 | 0.57 |
| EarningsYield | 0.09 | 0.06 | -0.29 | 0.01 | 0.04 |
After reviewing the key financial ratios for Bombay Burmah Trading Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 160.90. This value is within the healthy range. It has increased from 98.09 (Mar 24) to 160.90, marking an increase of 62.81.
- For Diluted EPS (Rs.), as of Mar 25, the value is 160.90. This value is within the healthy range. It has increased from 98.09 (Mar 24) to 160.90, marking an increase of 62.81.
- For Cash EPS (Rs.), as of Mar 25, the value is 340.69. This value is within the healthy range. It has increased from 320.35 (Mar 24) to 340.69, marking an increase of 20.34.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 807.16. It has decreased from 952.73 (Mar 24) to 807.16, marking a decrease of 145.57.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 807.16. It has decreased from 952.73 (Mar 24) to 807.16, marking a decrease of 145.57.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,622.54. It has increased from 2,450.67 (Mar 24) to 2,622.54, marking an increase of 171.87.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 487.98. This value is within the healthy range. It has decreased from 501.00 (Mar 24) to 487.98, marking a decrease of 13.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 441.18. This value is within the healthy range. It has decreased from 456.12 (Mar 24) to 441.18, marking a decrease of 14.94.
- For PBT / Share (Rs.), as of Mar 25, the value is 416.77. This value is within the healthy range. It has increased from 388.89 (Mar 24) to 416.77, marking an increase of 27.88.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 293.89. This value is within the healthy range. It has increased from 275.46 (Mar 24) to 293.89, marking an increase of 18.43.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 160.90. This value is within the healthy range. It has increased from 98.03 (Mar 24) to 160.90, marking an increase of 62.87.
- For PBDIT Margin (%), as of Mar 25, the value is 18.60. This value is within the healthy range. It has decreased from 20.44 (Mar 24) to 18.60, marking a decrease of 1.84.
- For PBIT Margin (%), as of Mar 25, the value is 16.82. This value is within the healthy range. It has decreased from 18.61 (Mar 24) to 16.82, marking a decrease of 1.79.
- For PBT Margin (%), as of Mar 25, the value is 15.89. This value is within the healthy range. It has increased from 15.86 (Mar 24) to 15.89, marking an increase of 0.03.
- For Net Profit Margin (%), as of Mar 25, the value is 11.20. This value exceeds the healthy maximum of 10. It has decreased from 11.24 (Mar 24) to 11.20, marking a decrease of 0.04.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.13. This value is below the healthy minimum of 8. It has increased from 4.00 (Mar 24) to 6.13, marking an increase of 2.13.
- For Return on Networth / Equity (%), as of Mar 25, the value is 19.93. This value is within the healthy range. It has increased from 14.63 (Mar 24) to 19.93, marking an increase of 5.30.
- For Return on Capital Employeed (%), as of Mar 25, the value is 35.48. This value is within the healthy range. It has decreased from 41.37 (Mar 24) to 35.48, marking a decrease of 5.89.
- For Return On Assets (%), as of Mar 25, the value is 8.82. This value is within the healthy range. It has increased from 5.72 (Mar 24) to 8.82, marking an increase of 3.10.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 0.2. It has decreased from 0.19 (Mar 24) to 0.12, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has decreased from 0.45 (Mar 24) to 0.27, marking a decrease of 0.18.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.48. It has increased from 1.24 (Mar 24) to 1.48, marking an increase of 0.24.
- For Current Ratio (X), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 1.5. It has decreased from 1.23 (Mar 24) to 1.07, marking a decrease of 0.16.
- For Quick Ratio (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. It has decreased from 0.93 (Mar 24) to 0.75, marking a decrease of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 14.35. This value exceeds the healthy maximum of 8. It has increased from 6.93 (Mar 24) to 14.35, marking an increase of 7.42.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 11.31. This value is below the healthy minimum of 20. It has increased from 1.22 (Mar 24) to 11.31, marking an increase of 10.09.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.76. This value is below the healthy minimum of 20. It has increased from 0.83 (Mar 24) to 8.76, marking an increase of 7.93.
- For Earning Retention Ratio (%), as of Mar 25, the value is 88.69. This value exceeds the healthy maximum of 70. It has decreased from 98.78 (Mar 24) to 88.69, marking a decrease of 10.09.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.24. This value exceeds the healthy maximum of 70. It has decreased from 99.17 (Mar 24) to 91.24, marking a decrease of 7.93.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 21.50. This value is within the healthy range. It has increased from 9.61 (Mar 24) to 21.50, marking an increase of 11.89.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 14.02. This value is within the healthy range. It has increased from 6.58 (Mar 24) to 14.02, marking an increase of 7.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 15,508.50. It has increased from 14,170.57 (Mar 24) to 15,508.50, marking an increase of 1,337.93.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has increased from 0.82 (Mar 24) to 0.84, marking an increase of 0.02.
- For EV / EBITDA (X), as of Mar 25, the value is 4.55. This value is below the healthy minimum of 5. It has increased from 4.05 (Mar 24) to 4.55, marking an increase of 0.50.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.67, marking an increase of 0.04.
- For Retention Ratios (%), as of Mar 25, the value is 88.68. This value exceeds the healthy maximum of 70. It has decreased from 98.77 (Mar 24) to 88.68, marking a decrease of 10.09.
- For Price / BV (X), as of Mar 25, the value is 2.19. This value is within the healthy range. It has decreased from 2.34 (Mar 24) to 2.19, marking a decrease of 0.15.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.67, marking an increase of 0.04.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.09, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bombay Burmah Trading Corporation Ltd:
- Net Profit Margin: 11.2%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 35.48% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 19.93% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 14.02
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.75
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.6 (Industry average Stock P/E: 73.82)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.27
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.2%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | 9, Wallace Street, Fort, Mumbai Maharashtra 400001 | investorservices@bbtcl.com http://www.bbtcl.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Nusli N Wadia | Chairman |
| Mr. Ness N Wadia | Managing Director |
| Mr. Jehangir N Wadia | Whole Time Director |
| Mr. Rajesh Batra | Director |
| Mr. Keki Manchersha Elavia | Director |
| Dr. Y S P Thorat | Director |
| Dr.(Mrs.) Minnie Bodhanwala | Director |
FAQ
What is the intrinsic value of Bombay Burmah Trading Corporation Ltd?
Bombay Burmah Trading Corporation Ltd's intrinsic value (as of 25 November 2025) is 1839.58 which is 1.20% lower the current market price of 1,862.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 13,001 Cr. market cap, FY2025-2026 high/low of 2,569/1,521, reserves of ₹5,618 Cr, and liabilities of 12,721 Cr.
What is the Market Cap of Bombay Burmah Trading Corporation Ltd?
The Market Cap of Bombay Burmah Trading Corporation Ltd is 13,001 Cr..
What is the current Stock Price of Bombay Burmah Trading Corporation Ltd as on 25 November 2025?
The current stock price of Bombay Burmah Trading Corporation Ltd as on 25 November 2025 is 1,862.
What is the High / Low of Bombay Burmah Trading Corporation Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bombay Burmah Trading Corporation Ltd stocks is 2,569/1,521.
What is the Stock P/E of Bombay Burmah Trading Corporation Ltd?
The Stock P/E of Bombay Burmah Trading Corporation Ltd is 11.6.
What is the Book Value of Bombay Burmah Trading Corporation Ltd?
The Book Value of Bombay Burmah Trading Corporation Ltd is 897.
What is the Dividend Yield of Bombay Burmah Trading Corporation Ltd?
The Dividend Yield of Bombay Burmah Trading Corporation Ltd is 0.91 %.
What is the ROCE of Bombay Burmah Trading Corporation Ltd?
The ROCE of Bombay Burmah Trading Corporation Ltd is 35.5 %.
What is the ROE of Bombay Burmah Trading Corporation Ltd?
The ROE of Bombay Burmah Trading Corporation Ltd is 21.9 %.
What is the Face Value of Bombay Burmah Trading Corporation Ltd?
The Face Value of Bombay Burmah Trading Corporation Ltd is 2.00.